Christina M Lockwood Selected Research

RNA (Ribonucleic Acid)

1/2022	Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinib.
10/2021	Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting.
1/2018	Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer.
4/2013	Circulating miR-122 as a potential biomarker of liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christina M Lockwood Research Topics

Disease

19	Neoplasms (Cancer) 06/2022 - 05/2013
3	Aneuploidy (Aneuploid) 09/2021 - 03/2018
2	Obesity 01/2022 - 09/2021
2	Astrocytoma (Pilocytic Astrocytoma) 11/2021 - 10/2018
2	Ganglioglioma 11/2021 - 10/2018
2	Glioma (Gliomas) 07/2020 - 01/2020
2	Microsatellite Instability 03/2020 - 01/2018
1	Neoplasm Metastasis (Metastasis) 11/2021
1	Autoimmune Diseases (Autoimmune Disease) 11/2021
1	COVID-19 10/2021
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Vomiting 07/2020
1	Thrombocytopenia (Thrombopenia) 07/2020
1	Nausea 07/2020
1	Carcinogenesis 01/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Circulating Neoplastic Cells 01/2020
1	Liver Failure 01/2020
1	Mesoblastic Nephroma (Congenital Mesoblastic Nephroma) 01/2018
1	Adenocarcinoma of Lung 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Fibrosarcoma 01/2018
1	Hemolysis 05/2017
1	Mycosis Fungoides 08/2015
1	Critical Illness (Critically Ill) 05/2014
1	Acute Kidney Injury (Acute Renal Failure) 05/2014
1	Oxyphilic Adenoma (Oncocytoma) 05/2013
1	Liver Diseases (Liver Disease) 04/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2013
1	Ectopic Pregnancy 05/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2009
1	Acute Coronary Syndrome 09/2009

Drug/Important Bio-Agent (IBA)

8	Cell-Free Nucleic AcidsIBA 06/2022 - 03/2018
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2014
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2009
4	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2013
3	NucleotidesIBA 12/2021 - 04/2014
2	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 11/2021 - 10/2018
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2018
2	Circulating Tumor DNAIBA 10/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2014
2	MicroRNAs (MicroRNA)IBA 05/2017 - 07/2013
2	ParaffinIBA 02/2015 - 04/2014
2	Formaldehyde (Formol)FDA Link 02/2015 - 04/2014
1	larotrectinibIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 11/2021
1	N-(4-isothiocyanatophenethyl)spiperoneIBA 09/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	Bevacizumab (Avastin)FDA Link 07/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2020
1	Temozolomide (Temodar)FDA LinkGeneric 07/2020
1	dipinacoline glutamateIBA 07/2020
1	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 01/2020
1	ChromatinIBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	MethyltransferasesIBA 01/2020
1	CrizotinibIBA 01/2018
1	ceritinibIBA 01/2018
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	AntibodiesIBA 01/2018
1	DiaminesIBA 05/2017
1	AcidsIBA 05/2017
1	ethyleneIBA 05/2017
1	Edetic Acid (EDTA)FDA Link 05/2017
1	Heparin (Liquaemin)FDA LinkGeneric 05/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2015
1	Inositol OxygenaseIBA 05/2014
1	Biological ProductsIBA 04/2014
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 05/2013
1	Keratin-7 (Cytokeratin 7)IBA 05/2013
1	IronIBA 05/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013
1	Circulating MicroRNAIBA 05/2012
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 05/2012
1	Progesterone FDA LinkGeneric 05/2012
1	pro-brain natriuretic peptide (1-76)IBA 09/2009
1	C-Reactive ProteinIBA 09/2009

Therapy/Procedure

5	Therapeutics 11/2021 - 12/2013
4	Drug Therapy (Chemotherapy) 01/2022 - 04/2014
1	Immunotherapy 01/2018